Kaiser Foundation Hospitals

Kaiser Foundation Hospitals was paid $93.22M by Medicaid between Jan 2018 and Dec 2024, across 438 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.

33Billing provider infoKAISER FOUNDATION HOSPITALS
SAN DIEGO, CA 92123

33aNPI1013062769assigned 01/24/2007

33bProvider typeGeneral Acute Care Hospital

28Total paid$93.22M

24GClaims2,741,215

24DCodes billed438

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#25 of 410

Median peer was paid$6.90M

This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	220,516	$6.64M
2019	356,343	$13.51M
2020	362,426	$16.75M
2021	430,840	$12.21M
2022	503,088	$14.81M
2023	428,577	$14.20M
2024incomplete	439,425	$15.09M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	39%	89,448	80,404	$36.07M
G0378	Hospital observation service, per hour	7.8%	11,605	7,164	$7.27M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	7.6%	12,126	11,521	$7.12M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.9%	10,072	9,771	$2.67M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	2.8%	2,846	2,779	$2.65M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.1%	8,280	8,072	$2.00M
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	1.8%	600	583	$1.68M
88305	Level IV - Surgical pathology, gross and microscopic examination	1.3%	28,802	21,095	$1.21M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	1.2%	1,924	1,911	$1.08M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.1%	3,254	3,210	$1.01M
70450	Computed tomography, head or brain; without contrast material	<1%	9,971	9,559	$895K
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,017	1,007	$878K

426 more codes

0450	Emergency room services	<1%	13,688	$799K
84443	Thyroid stimulating hormone (TSH)	<1%	50,811	$722K
71045	Radiologic examination, chest; single view	<1%	17,633	$721K
71046	Radiologic examination, chest; 2 views	<1%	14,333	$713K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	141,607	$627K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	7,474	$622K
86900		<1%	11,192	$616K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	21,901	$572K
99499		<1%	2,663	$508K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,819	$504K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	17,995	$489K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	5,151	$468K
82565		<1%	151,237	$460K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,881	$454K
86885		<1%	6,309	$448K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,771	$446K
83036	Hemoglobin; glycosylated (A1C)	<1%	55,292	$432K
80061	Lipid panel	<1%	37,063	$432K
76830	Ultrasound, transvaginal	<1%	4,668	$426K
85027		<1%	77,629	$423K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	13,337	$421K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	13,347	$420K
80051		<1%	118,786	$395K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,101	$391K
86480		<1%	6,028	$355K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,588	$346K
84460		<1%	89,965	$325K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	8,281	$293K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	19,914	$288K
73630		<1%	4,632	$257K
83970		<1%	7,367	$237K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	10,293	$230K
87505		<1%	2,654	$230K
82728		<1%	20,022	$229K
76770		<1%	2,650	$226K
83880		<1%	15,573	$221K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,417	$215K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	793	$208K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,895	$208K
84702		<1%	30,106	$207K
73562		<1%	3,815	$203K
86901		<1%	11,225	$198K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,243	$194K
73610		<1%	3,562	$192K
70544		<1%	1,037	$190K
76801		<1%	1,909	$189K
72141		<1%	966	$189K
86780		<1%	14,117	$189K
82247		<1%	63,857	$184K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,844	$184K
84075		<1%	61,725	$181K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	9,017	$179K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	3,485	$170K
73221		<1%	745	$165K
72100		<1%	1,917	$160K
73030		<1%	2,938	$160K
84520		<1%	98,151	$155K
82607		<1%	12,154	$152K
86141		<1%	16,482	$152K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,496	$147K
93971		<1%	947	$147K
83550		<1%	19,847	$146K
73130		<1%	2,608	$142K
84450		<1%	50,050	$138K
83735		<1%	35,539	$133K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	1,225	$133K
96375	Therapeutic injection; each additional sequential IV push	<1%	13,334	$132K
82947		<1%	82,935	$131K
73110		<1%	2,236	$121K
93970		<1%	512	$119K
86803		<1%	8,904	$118K
93017		<1%	871	$112K
83540		<1%	20,206	$107K
88342		<1%	806	$107K
99285	Emergency room visit (most serious)	<1%	140	$105K
83690		<1%	34,266	$103K
74183		<1%	306	$96K
87536		<1%	1,246	$96K
77080		<1%	879	$93K
85610		<1%	39,487	$91K
87088		<1%	20,037	$91K
82310		<1%	28,478	$90K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	601	$89K
A9585	Injection, gadobutrol, 0.1 ml	<1%	2,435	$89K
70486		<1%	833	$88K
76536		<1%	960	$87K
62323		<1%	152	$87K
76870		<1%	1,002	$86K
86923		<1%	890	$86K
87340		<1%	9,562	$86K
73502		<1%	1,586	$84K
74018		<1%	1,424	$84K
82746		<1%	6,806	$82K
93880		<1%	194	$82K
0710		<1%	1,529	$80K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	1,460	$79K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	6,285	$77K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,010	$77K
84132		<1%	18,701	$77K
88304		<1%	2,051	$76K
73140		<1%	1,340	$76K
81003		<1%	57,069	$74K
84484		<1%	27,190	$72K
J7030	Infusion, normal saline solution , 1000 cc	<1%	34,121	$71K
81513		<1%	914	$69K
83655		<1%	6,059	$67K
84295		<1%	15,405	$67K
83520		<1%	5,417	$66K
84403		<1%	2,614	$63K
82043		<1%	13,596	$62K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	11,020	$62K
73564		<1%	527	$61K
84439		<1%	8,416	$59K
82040		<1%	16,069	$57K
86762		<1%	3,823	$57K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	6,961	$57K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,324	$57K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	4,785	$56K
73080		<1%	1,088	$56K
0637		<1%	141,731	$56K
84153		<1%	3,883	$54K
82570		<1%	10,886	$53K
72197		<1%	151	$52K
73590		<1%	964	$52K
86787		<1%	3,968	$52K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,008	$51K
88312		<1%	822	$48K
90686		<1%	4,187	$47K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	2,065	$47K
77066	Tomosynthesis, mammo	<1%	297	$46K
85652		<1%	20,655	$46K
87040		<1%	16,563	$45K
82670		<1%	1,583	$45K
99199	Unlisted special service, procedure or report	<1%	2,179	$44K
84100		<1%	17,353	$41K
87497		<1%	1,143	$40K
70491		<1%	204	$39K
86665		<1%	2,334	$39K
82105		<1%	2,887	$39K
71101		<1%	394	$38K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	4,593	$37K
72050		<1%	327	$37K
84156		<1%	10,531	$36K
86038		<1%	3,460	$36K
83001		<1%	1,844	$35K
76641		<1%	336	$34K
87481		<1%	1,073	$34K
82248		<1%	10,747	$33K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	914	$33K
80197		<1%	2,972	$33K
86003		<1%	737	$33K
87210		<1%	7,672	$32K
72156		<1%	113	$32K
84146		<1%	1,662	$31K
73090		<1%	595	$31K
72158		<1%	99	$31K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	3,769	$30K
87449		<1%	3,083	$30K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	3,392	$29K
83021		<1%	1,510	$29K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	74	$28K
71250		<1%	245	$28K
83721		<1%	3,117	$27K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	16,292	$27K
73100		<1%	426	$27K
83605		<1%	10,619	$26K
84550		<1%	7,218	$26K
84134		<1%	2,458	$26K
85730		<1%	6,831	$26K
84165		<1%	3,037	$26K
70498		<1%	179	$25K
88341		<1%	421	$25K
82784		<1%	1,333	$25K
70496		<1%	167	$24K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,015	$24K
73660		<1%	384	$24K
P9021	Red blood cells, each unit	<1%	594	$24K
96361	Intravenous infusion, hydration; each additional hour	<1%	3,545	$24K
72070		<1%	229	$24K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	11,986	$23K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,416	$22K
85379		<1%	5,530	$22K
80076		<1%	3,915	$22K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	706	$22K
86704		<1%	2,248	$21K
87324		<1%	2,642	$20K
73522		<1%	179	$20K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,247	$19K
82330		<1%	2,077	$18K
88307		<1%	168	$18K
80164		<1%	1,939	$18K
82950		<1%	3,776	$18K
86317		<1%	1,386	$18K
83615		<1%	3,921	$17K
85014		<1%	9,132	$17K
82077		<1%	3,038	$17K
86225		<1%	1,387	$17K
0370		<1%	2,245	$17K
J1170	Injection, hydromorphone, up to 4 mg	<1%	4,630	$17K
76380		<1%	244	$17K
64483		<1%	13	$17K
86664		<1%	1,170	$16K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,556	$16K
82977		<1%	2,342	$16K
74170		<1%	68	$16K
82550		<1%	4,581	$15K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,782	$15K
83993		<1%	729	$14K
83002		<1%	742	$14K
83718		<1%	1,984	$13K
84163		<1%	856	$13K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	695	$13K
86431		<1%	2,256	$12K
87081		<1%	2,766	$12K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	951	$12K
80306		<1%	1,786	$12K
73552		<1%	195	$12K
86160		<1%	447	$10K
85046		<1%	2,065	$10K
70543		<1%	27	$10K
82150		<1%	1,848	$10K
85018		<1%	5,751	$10K
86360		<1%	362	$10K
86677		<1%	908	$10K
A9609	Fludeoxyglucose f18 up to 15 millicuries	<1%	211	$10K
G0008	Administration of influenza virus vaccine	<1%	3,436	$10K
82951		<1%	653	$10K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	514	$10K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	387	$9K
84480		<1%	843	$9K
73560		<1%	140	$9K
87070		<1%	2,239	$9K
76813		<1%	93	$9K
73700		<1%	93	$9K
87205		<1%	3,439	$9K
80179		<1%	1,505	$8K
84155		<1%	2,167	$8K
82465		<1%	2,275	$8K
86359		<1%	362	$8K
74174		<1%	27	$8K
87186		<1%	2,336	$8K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,666	$8K
0250		<1%	13,582	$7K
82627		<1%	305	$7K
84270		<1%	341	$7K
74022		<1%	80	$7K
96367		<1%	870	$7K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,511	$7K
86308		<1%	1,497	$7K
J3490	Unclassified drugs	<1%	8,186	$7K
Z7502		<1%	598	$6K
86765		<1%	519	$6K
72110		<1%	52	$6K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,967	$6K
J1815	Injection, insulin, per 5 units	<1%	5,497	$6K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	634	$6K
82785		<1%	371	$6K
73060		<1%	115	$6K
72170		<1%	57	$6K
77072		<1%	59	$6K
86140		<1%	2,064	$6K
J3360	Injection, diazepam, up to 5 mg	<1%	930	$6K
82378		<1%	488	$6K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,129	$6K
87522	Neg quan hep c or qual rna	<1%	208	$6K
82805		<1%	865	$6K
72040		<1%	94	$6K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,719	$5K
86769		<1%	256	$5K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,174	$5K
74178		<1%	13	$5K
C1769	Guide wire	<1%	277	$5K
J1644	Injection, heparin sodium, per 1000 units	<1%	3,834	$5K
97161		<1%	587	$5K
V2632	Posterior chamber intraocular lens	<1%	297	$4K
80321		<1%	108	$4K
80178		<1%	929	$4K
86364		<1%	361	$4K
87517		<1%	106	$4K
86708		<1%	391	$4K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,929	$4K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,372	$4K
76706		<1%	242	$3K
72081		<1%	61	$3K
73718		<1%	12	$3K
87631		<1%	151	$3K
J2060	Injection, lorazepam, 2 mg	<1%	2,408	$3K
82962		<1%	4,232	$3K
84145		<1%	1,415	$3K
90749		<1%	185	$3K
86709		<1%	381	$3K
86256		<1%	193	$3K
82952		<1%	623	$3K
82140		<1%	605	$3K
89051		<1%	713	$3K
90656		<1%	715	$3K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	13	$3K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	25	$2K
82272		<1%	599	$2K
86376		<1%	170	$2K
80156		<1%	237	$2K
73000		<1%	29	$2K
90688		<1%	170	$2K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	237	$2K
82533		<1%	127	$2K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	286	$2K
80162		<1%	129	$2K
82677		<1%	55	$2K
84425		<1%	81	$2K
81015		<1%	513	$1K
86635		<1%	148	$1K
73070		<1%	25	$1K
90791	Psychiatric diagnostic evaluation	<1%	77	$1K
88184		<1%	12	$1K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,921	$1K
80359		<1%	142	$1K
85045		<1%	424	$1K
86039		<1%	166	$1K
77063	Screening digital breast tomosynthesis, bilateral	<1%	62	$1K
80324		<1%	142	$1K
0258		<1%	2,572	$1K
74230		<1%	13	$1K
86235		<1%	27	$1K
J1940	Injection, furosemide, up to 20 mg	<1%	2,334	$1K
86336		<1%	55	$973.00
86335		<1%	25	$805.57
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,173	$803.21
83935		<1%	275	$721.30
72220		<1%	13	$712.90
90662		<1%	424	$689.31
87102		<1%	107	$688.30
83930		<1%	297	$676.54
86334		<1%	57	$641.07
86735		<1%	57	$634.21
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	24	$621.37
87807		<1%	262	$575.12
84478		<1%	125	$567.00
74240		<1%	13	$558.00
85613		<1%	65	$535.66
0255		<1%	174	$532.14
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	147	$493.42
80048	Basic metabolic panel (calcium, ionized)	<1%	88	$480.43
97162		<1%	128	$470.81
J1836	Injection, metronidazole, 10 mg	<1%	451	$469.49
87116		<1%	51	$449.76
J2550	Injection, promethazine hcl, up to 50 mg	<1%	362	$437.54
87075		<1%	88	$406.00
87045		<1%	62	$404.50
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	281	$404.09
80185		<1%	28	$395.39
0272		<1%	237	$386.31
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	60	$362.08
J1630	Injection, haloperidol, up to 5 mg	<1%	195	$350.57
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	37	$342.66
85384		<1%	111	$339.42
90674		<1%	15	$325.90
86880		<1%	13	$306.99
90715		<1%	42	$304.44
J3370	Injection, vancomycin hcl, 500 mg	<1%	193	$298.31
84590		<1%	54	$282.69
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	223	$279.35
C9113	Injection, pantoprazole sodium, per vial	<1%	805	$269.70
97116		<1%	182	$267.37
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	139	$256.68
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	71	$251.42
C1729	Catheter, drainage	<1%	27	$237.91
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	88	$225.57
87327		<1%	17	$213.13
85049		<1%	52	$206.86
87046		<1%	13	$200.00
87206		<1%	43	$185.87
87149		<1%	113	$174.41
83525		<1%	13	$158.00
83010		<1%	12	$148.00
82705		<1%	26	$141.00
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	<1%	42	$140.28
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	18	$138.50
12001		<1%	30	$134.69
82390		<1%	12	$120.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	48	$112.00
87338		<1%	12	$88.00
80175		<1%	13	$83.72
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,627	$72.32
85670		<1%	14	$70.00
J1335	Injection, ertapenem sodium, 500 mg	<1%	28	$56.52
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	30	$45.07
J2470	Injection, pantoprazole sodium, 40 mg	<1%	190	$40.26
J3411	Injection, thiamine hcl, 100 mg	<1%	44	$34.75
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	67	$34.10
80320		<1%	49	$33.00
87184		<1%	17	$32.85
J0456	Injection, azithromycin, 500 mg	<1%	65	$20.47
29125		<1%	28	$17.17
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	29	$5.81
C1758	Catheter, ureteral	<1%	60	$4.97
J8540	Dexamethasone, oral, 0.25 mg	<1%	28	$1.53
3052F		<1%	175	$0.01
3046F		0%	362	$0.00
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	0%	166	$0.00
3051F		0%	384	$0.00
3078F		0%	120	$0.00
76942		0%	12	$0.00
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	0%	38	$0.00
11721		0%	55	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	177	$0.00
92134		0%	47	$0.00
82274		0%	364	$0.00
92015	Determination of refractive state	0%	29	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	24	$0.00
92610		0%	15	$0.00
99204	Doctor's office visit, new patient (more involved)	0%	13	$0.00
87255		0%	14	$0.00
99213	Doctor's office visit, returning patient (routine)	0%	257	$0.00
86592		0%	12	$0.00
3044F		0%	6,547	$0.00
J2280	Injection, moxifloxacin, 100 mg	0%	160	$0.00
88185		0%	12	$0.00
11055		0%	14	$0.00
3074F		0%	149	$0.00
90935	Hemodialysis procedure with single evaluation by a physician	0%	38	$0.00
83921		0%	27	$0.00
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	0%	62	$0.00
99214	Doctor's office visit, returning patient (more involved)	0%	54	$0.00
92227		0%	208	$0.00
J8501	Aprepitant, oral, 5 mg	0%	13	$0.00
80329		0%	37	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFINLEY, ELIZABETH (SENIOR VICE PRESIDENT, AREA MANAGER)

Same official

Other billing entities under FINLEY, ELIZABETH

Full network →

Provider	Location	Paid
Kaiser Foundation Hospitals	San Marcos, CA	$5.33M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.